Toxoplasmosis is an infectious disease caused by the parasite Toxoplasma gondii. Despite being asymptomatic when affects immunocompetent individuals, it is high risk to infected pregnant women and their babies by the adverse effects it can generate. The aim of this project is to evaluate pregnant women with suspected pregnancy / congenital toxoplasmosis. Specific objectives include: 1. assess the clinical condition of pregnant women infected with T. gondii during prenatal care; 2. identify the recommended treatment during pregnancy; 3. identify and assess the conditions presented by the newborns; 4. identify and evaluate the conditions of children and the answers to these treatment continued for at least the first 18 months after birth. Will be evaluated the data of pregnant women such as gestational age, appropriate treatment, clinical diagnosis, laboratory diagnosis, among others that may be relevant in the clinical evaluation. Especially of pregnant women who underwent amniocentesis for the molecular diagnosis of toxoplasmosis by PCR (Polymerase Chain Reaction), featuring fetal infection by T. gondii. Serological data will be analyzed (used methods, antibody classes identified, etc.); of their newborns and children will be assessed the neurological development, auditory, visual, appropriate treatment and other medical conditions potentially related to toxoplasmosis and correlated with maternal conditions and their potential relationships of cause and effect. The data collected will be compared using the Fisher exact test and the chi-square or (where appropriate) and t test (for continuous variables). They will also calculate the values of odds ratios and confidence interval of 95%. The alpha value adopted will be 5%. It is expected that the results may contribute to elucidate the effects of gestational and congenital infections by T. gondii in affected children.
News published in Agência FAPESP Newsletter about the scholarship: